| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ANI PHARMACEUTICALS INC | Director | Common Stock | 22.6K | $1.39M | $61.61 | May 21, 2024 | Direct |
| Cardiff Oncology, Inc. | Director | Stock Options | 128K | $333K | $2.60 | Jun 27, 2024 | Direct |
| ZOGENIX, INC. | Director | Common Stock | 0 | $26.04 | Mar 7, 2022 | Direct | |
| ZOGENIX, INC. | Director | Stock Option (Right to Buy) | 0 | $26.09 | Mar 7, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CRDF | Cardiff Oncology, Inc. | Jun 27, 2024 | 1 | $0 | 4 | Jul 1, 2024 | Director |
| ANIP | ANI PHARMACEUTICALS INC | May 21, 2024 | 1 | $0 | 4 | May 23, 2024 | Director |
| ANIP | ANI PHARMACEUTICALS INC | May 16, 2024 | 1 | -$128K | 4 | May 17, 2024 | Director |
| CRDF | Cardiff Oncology, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
| ANIP | ANI PHARMACEUTICALS INC | May 23, 2023 | 1 | $0 | 4 | May 24, 2023 | Director |
| CRDF | Cardiff Oncology, Inc. | Sep 15, 2022 | 2 | $17.2K | 4 | Sep 19, 2022 | Director |
| ANIP | ANI PHARMACEUTICALS INC | Mar 19, 2022 | 1 | $0 | 4 | Mar 22, 2022 | Director |
| ANIP | ANI PHARMACEUTICALS INC | Mar 19, 2022 | 0 | $0 | 3 | Mar 22, 2022 | Director |
| CRDF | Cardiff Oncology, Inc. | Mar 9, 2022 | 1 | $0 | 4 | Mar 10, 2022 | Director |
| ZGNX | ZOGENIX, INC. | Mar 7, 2022 | 3 | $0 | 4 | Mar 9, 2022 | Director |
| ZGNX | ZOGENIX, INC. | Nov 29, 2021 | 1 | -$62.2K | 4 | Nov 30, 2021 | Director |
| CRDF | Cardiff Oncology, Inc. | Jun 10, 2021 | 1 | $0 | 4 | Jun 14, 2021 | Director |
| CRDF | Cardiff Oncology, Inc. | Jun 10, 2021 | 0 | $0 | 3 | Jun 14, 2021 | Director |
| ZGNX | ZOGENIX, INC. | Jun 1, 2021 | 1 | $85.2K | 4 | Jun 3, 2021 | Director |
| ZGNX | ZOGENIX, INC. | May 27, 2021 | 1 | $0 | 4 | May 28, 2021 | Director |